BCL2 and B-cell chronic lymphocytic leukemia: This hypothesis also is supported by the therapeutic effects observed in CLL patients with BH3 mimics, which, by inhibiting the anti-apoptotic effects of the bcl-2 family molecules, swing the balance toward the induction of apoptosis [145].